intoxicant.wiki2catechol4school
Layout
Dissociative

PCE

Also called Eticyclidine, N-Ethyl-1-phenylcyclohexylamine, Ethylphencyclidine, N-Ethyl-1-phenylcyclohexanamine

Why a "revision used" link? Anyone can edit Wikipedia at any time, so the article you open today may not say what it said when we read it. This link opens the exact version we read on 24 October 2026, frozen as it was. It is the only way to check that every quote on this page matches its source word for word. Newer versions may correct or change things. When we re-check this page against a newer version, the edit log records it. How we cite

Common dose · Oral5–10 mg PW
Onset30–90 minutes PW
Total4–8 hours PW
After-effects4–48 hours PW

Dosage

When sources disagree, both rows are shown as published. Nothing is averaged or merged.

Oral

SourceThresholdLightCommonStrongHeavy
PsychonautWiki1 mg PW3–5 mg PW5–10 mg PW10–15 mg PW15 mg+ Heavy doses may result in psychosis and mania.[6] PW

Smoked

SourceThresholdLightCommonStrongHeavy
PsychonautWiki1 mg PW2–4 mg PW4–8 mg PW8–12 mg PW12 mg+ Heavy doses may result in psychosis and mania.[6] PW

Insufflated

SourceThresholdLightCommonStrongHeavy
PsychonautWiki1 mg PW2–4 mg PW4–8 mg PW8–15 mg PW15 mg+ Heavy doses may result in psychosis and mania.[6] PW
TripSit–1–3 mg TS3–7 mg TS7–15 mg+ TS–

TripSit dose text

TripSit's factsheet also states its doses as text.

Insufflated Light: 1-3mg Common: 3-7mg Strong: 7-15mg+ TS

What dose are you on? (self-reported, unverified)
Read this first. These numbers come from anonymous visitors typing in a box. Nobody checks them. People misjudge, mistype, troll, or take untested products of unknown strength. They are not a dose guide and never override the sourced table above. They exist only so the sourced ranges can be compared with what people say they take. If you are deciding what to take, use the sourced table, start low, and read the risks section.
Running self-reports

No reports yet.

Reports are anonymous, one per browser per day per route. Counts under 20 are shown but marked as too few to mean anything. Until accounts launch, reports stay in this browser only.

Duration

Route · sourceOnsetCome-upPeakOffsetTotalAfter-effects
Oral · PsychonautWiki30–90 minutes PW40–120 minutes PW2–3 hours PW1–2 hours PW4–8 hours PW4–48 hours PW
Smoked · PsychonautWiki2–20 minutes PW20–40 minutes PW2–3 hours PW1–2 hours PW4–6 hours PW4–48 hours PW
Insufflated · PsychonautWiki3–30 minutes PW30–90 minutes PW2–3 hours PW1–2 hours PW4–6 hours PW4–48 hours PW

TripSit factsheet

Duration
2-5 hours TS
Aftereffects
1-4 hours TS
Onset
Insufflated 5-15 minutes. TS

Mixing

Acute combinations: what happens when these are taken close together. Entries backed by a medical journal or agency are listed first.

Backed by medical journals

Awaiting sourcePeer-reviewed reports on acute combinations, from PubMed and the journals the harm reduction sites cite.

Other documented combinations

  • Psychedelics - This combination is not advised because PCE has been reported to cause extreme psychological disturbances such as psychosis and mania at a significantly higher rate than other dissociatives. PW⚠ PsychonautWiki lists this combination without a danger rating.

PsychonautWiki also lists dangerous combinations shared across a whole group (dissociatives) in a table this page does not copy. Read that list on PsychonautWiki.

Risks and toxicity

The long-term use of PCE may lead to schizophrenia-like psychotic episodes, severe lasting memory loss, disorganized thinking, depression, weight loss, liver abnormalities and rhabdomyolysis (skeletal muscle breakdown).[7] PW

Some studies have found that, like other NMDA receptor antagonists, PCE can cause brain damage called Olney's lesions in rats. Studies conducted on rats showed that high doses of the NMDA receptor antagonist dizocilpine caused reversible vacuoles to form in certain regions of the rats' brains. All studies of Olney's lesions have only been performed on non-human animals and may not apply to humans.[8][9] PW

PCE has also been shown to cause schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate levels in the rat brain, which are detectable both in living rats and upon necropsy examination of brain tissue. It also induces symptoms in humans that mimic schizophrenia.[10][11] PW

It is strongly recommended that one use harm reduction practices, such as volumetric dosing, when using this substance to ensure the administration of the intended dose. PW

Tolerance and addiction potential

The chronic use of PCE can be considered highly addictive with a high potential for adverse side effects such as psychosis. In comparison to other dissociatives, PCE has been reported to be more addictive than MXE, diphenidine, ephenidine, and ketamine. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage. There have been multiple reports across the internet of people becoming seriously addicted daily users of this substance so serious precautions and considerations should be taken before trying this substance. PW

Tolerance to many of the effects of PCE develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). PCE presents cross-tolerance with all dissociatives, meaning that after the consumption of PCE, all dissociatives will have a reduced effect. PW

Psychosis

PCE is reported to cause psychosis and mania at a significantly higher rate than other dissociatives such as ketamine, diphenidine, or MXE. Multiple scientific papers describe states of psychosis, mania, and/or delirium occurring after moderate to large doses of the drug were ingested. In one initial human trial, it was reported that one-sixth of the patients who had received anesthetic doses became psychotic. In some cases, it took up to a week or more to resolve. Similar results (although less severe) were reported during trials using subanesthetic doses of PCE for pain relief.[12] PW

It is strongly recommended that one use extreme caution and harm reduction practices when using this drug. PW

  • Users should avoid taking the drug multiple days in a row or becoming addicted to it as this increases the risk of severe adverse effects. PW
  • The recommended dosage range should not be exceeded as high doses can trigger adverse effects. PW
  • Users should start with extremely low doses and work their way up as slowly as possible. Volumetric liquid dosing should preferably be used due to the drug's potency; most standard milligram scales cannot accurately weigh out doses below 10-15mg. PW
  • Compulsive redosing before one has fully sobered up is not recommended and can result in too high of a dose. PW

Due to the risk of psychosis, it is not recommended to combine this drug with other substances, especially stimulants, psychedelics, or other dissociatives like MXE. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption. PW

Urinary tract effects

In terms of its long-term health effects when used repeatedly and excessively for extended periods of time, PCE seems to exhibit similar extreme bladder and urinary tract problems to those found with other arylcyclohexylamines like ketamine or PCP. PW

  • Urinary frequency - Urinary frequency is the need to empty the bladder every few minutes. PW
  • Urinary urgency - This can be described as a sudden, compelling need to urinate. PW
  • Urinary pressure - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination. PW
  • Pelvic and bladder pain - Pain can develop suddenly and severely, particularly as the bladder fills with urine. PW
  • Hematuria - Hematuria is visible blood in the urine. PW
  • Incontinence - This is the leakage of urine. PW

A large body of anecdotal evidence suggests that these symptoms can be minimized by not using PCE on a regular basis (daily or weekly at the bare minimum) and carefully monitoring and limiting one's usage of the substance, although general usage of this substance is still discouraged due to its observed toxic properties. PW

Testing

Awaiting sourceReagent reactions and test kit guidance from a harm reduction testing service.

Effects

Awaiting sourceSubjective and physical effects from PsychonautWiki or TripSit.

Overview

PCE (also known as Eticyclidine or CI-400) is a synthetic dissociative substance of the arylcyclohexylamine chemical class that produces dissociative, anesthetic and hallucinogenic effects when administered. Like its closely related structural analog PCP, PCE primarily exerts its effect as an NMDA receptor antagonist, where it noncompetitively binds to and blocks the activity of the NMDA receptor.[1][2][3] PW

Eticyclidine (PCE) is a Dissociative anesthetic that has hallucinogenic effects. Slightly more potent than Phencyclidine. TS

PCE (Eticyclidine, CI-400) is a dissociative anesthetic drug with hallucinogenic effects. It is similar in effects to phencyclidine but is slightly more potent. PCE was developed by Parke-Davis in the 1970s and evaluated for anesthetic potential under the code name CI-400, but research into PCE was not continued after the development of ketamine, a similar drug with more favourable properties. Due to its similarity in effects to PCP, PCE was placed into the Schedule 1 list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known.[1][4][5] WP

History

Awaiting sourceHistory and culture from Wikipedia or PsychonautWiki, with their citations.

Pharmacology

Awaiting sourcePharmacology from Wikipedia and the journal papers it cites.

Chemistry

Formula
C14H21N PC
CAS number
2201-15-2 PC
Molar mass (g/mol)
203.32 PC
IUPAC name (computed by PubChem)
N-ethyl-1-phenylcyclohexan-1-amine PC
SMILES
CCNC1(CCCCC1)C2=CC=CC=C2 PC
InChIKey
IFYLVUHLOOCYBG-UHFFFAOYSA-N PC
PubChem CID
16622

User reports

Erowid erowid.org

Listings
Awaiting sourceExperience Vault listing and report categories.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Bluelight bluelight.org

Listings
Awaiting sourceTrip report threads and this substance's discussion forum.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Reddit reddit.com

Listings
Awaiting sourceTrip report posts and the relevant subreddits.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Pop culture

No references added yet.

Add a reference

Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.

Opens when accounts launch.

References

  1. Journal / agency Morris, H., Wallach, J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis. August 2014. doi:10.1002/dta.1620
  2. Other McKim, W. A. Drugs and behavior: an introduction to behavioral pharmacology. 2000
  3. Journal / agency Kapur, S., Seeman, P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia. Molecular Psychiatry. September 2002. doi:10.1038/sj.mp.4001093
  4. Journal / agency Levy L, Cameron DE, Aitken RC. Observation on two psychotomimetic drugs of piperidine derivation--CI 395 (sernyl) and CI 400. The American Journal of Psychiatry. March 1960. doi:10.1176/ajp.116.9.843 · PMID 14416411
  5. Journal / agency Kalir A, Edery H, Pelah Z, Balderman D, Porath G. 1-Phenycycloalkylamine derivatives. II. Synthesis and pharmacological activity. Journal of Medicinal Chemistry. May 1969. doi:10.1021/jm00303a030 · PMID 4977945
  6. Harm reduction site PCP Psychosis (PsychonautWiki)
  7. Harm reduction site PCE Effects by Erowid
  8. Journal / agency Olney, J. W., Labruyere, J., Price, M. T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (New York, N.Y.). 16 June 1989. doi:10.1126/science.2660263
  9. Journal / agency Hargreaves, R. J., Hill, R. G., Iversen, L. L. Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology. Acta Neurochirurgica. Supplementum. 1994. doi:10.1007/978-3-7091-9334-1_4
  10. Journal / agency Reynolds, L. M., Cochran, S. M., Morris, B. J., Pratt, J. A., Reynolds, G. P. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophrenia Research. 1 March 2005. doi:10.1016/j.schres.2004.02.003
  11. Journal / agency Murray, J. B. Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research. The Journal of Psychology. May 2002. doi:10.1080/00223980209604159
  12. Other Tasman, A., Kay, J., Lieberman, J. A., First, M. B., Riba, M. Psychiatry. 5 February 2015
  13. Other List of psychotropic substances under international control (Green List). August 2003
  14. Other Anlage I BtMG - Einzelnorm
  15. Other Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien

Text and values on this page are quoted from PsychonautWiki (CC BY-SA 4.0), Wikipedia (CC BY-SA 4.0), TripSit factsheets, PubChem (public domain). Each value links to the exact revision it came from.